Invasive mould disease: A critical concern for immunocompromised patients
14 Nov 2025
During the recent Masterclass in Infectious Disease Summit Programme (MISP) Season 2, sponsored by Pfizer, Dr Asok Kurup, an infectious disease physician and chair of the Infection Control Committee at Mount Elizabeth, Singapore, discussed treatment challenges in invasive mould disease (IMD), guideline recommendations, the role of isavuconazole, and antifungal stewardship to combat antifungal resistance.
Resources
Invasive mould disease: A critical concern for immunocompromised patients
Invasive mould disease: A critical concern for immunocompromised patients